The neuromuscular blocking properties of 4,4'(2-(4-methyl-piperidyl)-1-hydroxyethyl) biphenyl.
D000818:Animals; D001713:Biphenyl Compounds / Q000494:pharmacology*; D002110:Caffeine / Q000494:pharmacology; D002118:Calcium / Q000494:pharmacology; D003080:Cold Temperature; D003864:Depression, Chemical; D003964:Diaphragm / Q000187:drug effects; D004558:Electric Stimulation; D000431:Ethanol / Q000494:pharmacology; D066298:In Vitro Techniques; D009119:Muscle Contraction / Q000187:drug effects*; D009469:Neuromuscular Junction / Q000187:drug effects* / Q000502:physiology; D009994:Osmolar Concentration; D010276:Parasympatholytics / Q000494:pharmacology*; D010791:Phrenic Nerve / Q000187:drug effects; D010880:Piperidines / Q000494:pharmacology*; D011189:Potassium Chloride / Q000494:pharmacology; D051381:Rats
D001713:Biphenyl Compounds; D010276:Parasympatholytics; D010880:Piperidines; D002110:Caffeine; D000431:Ethanol; D011189:Potassium Chloride; D002118:Calcium